Drugs & Diseases

Recent Drug Updates

  • pembrolizumab (Keytruda) FDA approves PD-L1 inhibitor in combination with lenvatinib for advanced endometrial cancer
  • ceftaroline (Teflaro) Indication for acute bacterial skin and skin structure infections expanded to include all children, including newborns
  • mepolizumab (Nucala) FDA expands indication for asthma to include patients aged 6 years and older
  • tenapanor (Ibsrela) FDA approves NHE3 inhibitor for IBS-C
  • glucagon (Gvoke) FDA approves new ready-to-use pen for severe hypoglycemia in patients with diabetes
  • nintedanib (Ofev) FDA approves first treatment for systemic sclerosis-associated interstitial lung disease

Slideshow Collections